share_log

Transcode Therapeutics | 8-K: Current report

SEC announcement ·  Jan 8 00:00
Summary by Moomoo AI
TransCode Therapeutics, Inc., a biotechnology company, held a Special Meeting of Stockholders on January 8, 2024. During the meeting, stockholders voted on two key proposals. The first proposal was to approve an amendment for a reverse stock split of the company's common stock, with a ratio ranging from 1-for-10 to 1-for-40, at the discretion of the Board of Directors. The second proposal was to approve the adjournment of the Special Meeting if there were insufficient votes to pass the reverse stock split. Both proposals were described in the Company’s Definitive Proxy Statement filed on December 18, 2023. The total number of shares entitled to vote was 25,097,596, with 12,472,113 shares present or represented by proxy. The Reverse Stock Split Proposal received 7,081,896 votes for, 5,348,629 against, and 41,588 abstentions. The Adjournment Proposal received 7,426,024 votes for, 4,836,062 against, and 210,027 abstentions. Both proposals were approved by the stockholders, and no adjournment was necessary as the reverse stock split proposal passed without requiring additional votes.
TransCode Therapeutics, Inc., a biotechnology company, held a Special Meeting of Stockholders on January 8, 2024. During the meeting, stockholders voted on two key proposals. The first proposal was to approve an amendment for a reverse stock split of the company's common stock, with a ratio ranging from 1-for-10 to 1-for-40, at the discretion of the Board of Directors. The second proposal was to approve the adjournment of the Special Meeting if there were insufficient votes to pass the reverse stock split. Both proposals were described in the Company’s Definitive Proxy Statement filed on December 18, 2023. The total number of shares entitled to vote was 25,097,596, with 12,472,113 shares present or represented by proxy. The Reverse Stock Split Proposal received 7,081,896 votes for, 5,348,629 against, and 41,588 abstentions. The Adjournment Proposal received 7,426,024 votes for, 4,836,062 against, and 210,027 abstentions. Both proposals were approved by the stockholders, and no adjournment was necessary as the reverse stock split proposal passed without requiring additional votes.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more